Leonard S. Schleifer - May 13, 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Bd. Co-Chair, President & CEO, Director
Signature
/s/**Leonard S. Schleifer
Stock symbol
REGN
Transactions as of
May 13, 2024
Transactions value $
-$95,075,310
Form type
4
Date filed
5/15/2024, 06:10 PM
Previous filing
Dec 13, 2023
Next filing
May 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock +Options Exercise $81,212,511 +203,204 +54.27% $399.66 577,633 May 13, 2024 Direct F1
transaction REGN Common Stock -Tax liability -$141,080,710 -144,433 -25% $976.79 433,200 May 13, 2024 Direct F1
transaction REGN Common Stock -Sell -$22,224,974 -22,698 -5.24% $979.16 410,502 May 14, 2024 Direct F1, F2
transaction REGN Common Stock -Sell -$2,256,190 -2,302 -0.56% $980.10 408,200 May 14, 2024 Direct F1, F3
transaction REGN Common Stock -Sell -$7,699,249 -7,864 -1.93% $979.05 400,336 May 15, 2024 Direct F1, F4
transaction REGN Common Stock -Sell -$289,289 -295 -0.07% $980.64 400,041 May 15, 2024 Direct F1, F5
transaction REGN Common Stock -Sell -$1,061,002 -1,081 -0.27% $981.50 398,960 May 15, 2024 Direct F1, F6
transaction REGN Common Stock -Sell -$230,925 -235 -0.06% $982.66 398,725 May 15, 2024 Direct F1, F7
transaction REGN Common Stock -Sell -$245,978 -250 -0.06% $983.91 398,475 May 15, 2024 Direct F1, F8
transaction REGN Common Stock -Sell -$300,120 -305 -0.08% $984.00 398,170 May 15, 2024 Direct F1, F9
transaction REGN Common Stock -Sell -$276,987 -281 -0.07% $985.72 397,889 May 15, 2024 Direct F1, F10
transaction REGN Common Stock -Sell -$101,617 -103 -0.03% $986.57 397,786 May 15, 2024 Direct F1, F11
transaction REGN Common Stock -Sell -$225,141 -228 -0.06% $987.46 397,558 May 15, 2024 Direct F1, F12
transaction REGN Common Stock -Sell -$295,639 -299 -0.08% $988.76 397,259 May 15, 2024 Direct F1, F13
holding REGN Common Stock 250,000 May 13, 2024 2023 GRAT
holding REGN Common Stock 5,932 May 13, 2024 By 401(k) Plan
holding REGN Common Stock 64,985 May 13, 2024 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) -Options Exercise $0 -203,204 -100% $0.00 0 May 13, 2024 Common Stock 203,204 $399.66 Direct F1, F14

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 5, 2024.
F2 Represents volume-weighted average price of sales of 22,698 shares of Company stock on May 14, 2024 at prices ranging from $979.00 to $979.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 14, 2024 at each separate price.
F3 Represents volume-weighted average price of sales of 2,302 shares of Company stock on May 14, 2024 at prices ranging from $980.00 to $980.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 14, 2024 at each separate price.
F4 Represents volume-weighted average price of sales of 7,864 shares of Company stock on May 15, 2024 at prices ranging from $979.00 to $979.50. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
F5 Represents volume-weighted average price of sales of 295 shares of Company stock on May 15, 2024 at prices ranging from $980.17 to $980.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
F6 Represents volume-weighted average price of sales of 1,081 shares of Company stock on May 15, 2024 at prices ranging from $981.09 to $981.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
F7 Represents volume-weighted average price of sales of 235 shares of Company stock on May 15, 2024 at prices ranging from $982.31 to $982.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
F8 Represents volume-weighted average price of sales of 250 shares of Company stock on May 15, 2024 at prices ranging from $983.82 to $983.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
F9 Represents volume-weighted average price of sales of 305 shares of Company stock on May 15, 2024 at prices ranging from $984.00 to $984.02. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
F10 Represents volume-weighted average price of sales of 281 shares of Company stock on May 15, 2024 at prices ranging from $985.13 to $985.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
F11 Represents volume-weighted average price of sales of 103 shares of Company stock on May 15, 2024 at prices ranging from $986.37 to $986.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
F12 Represents volume-weighted average price of sales of 228 shares of Company stock on May 15, 2024 at prices ranging from $987.31 to $987.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
F13 Represents volume-weighted average price of sales of 299 shares of Company stock on May 15, 2024 at prices ranging from $988.00 to $988.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
F14 The stock option award vests in four equal annual installments, commencing one year after the date of grant.